Experts on the panel shared many of the same views around SSRIs, arguing that the risks of the drugs during pregnancy are greater than currently accepted.

There were warnings to the FDA about Sarepta Therapeutics Inc. before US regulators asked the company to halt shipments of its gene therapy.

The FDA has issued Class I recalls for chocolate products due to undeclared allergens and contamination—posing serious health ...

The U.S. Food and Drug Administration (FDA) announced plans to update its food safety post-market chemical review program ...

FDA released a press release yesterday which announced it was either revoking or proposing to revoke fifty-two “obsolete and unnecessary” standards of identity (SOI) for various food products ...

Nirwana Foods recalls 28-oz golden raisins for undeclared sulfites that could cause life-threatening allergic reactions.

The FDA asked Sarepta Therapeutics to halt shipments of its Elevidys gene therapy after a patient's death linked to a similar treatment. Sarepta will continue shipments for ambulatory patients but ...

CCHR urges urgent reforms to ensure families are fully informed about life-threatening side effects of ADHD psychotropics and ...

Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of GSK plc’s ...

FDA issues warning letters to distributors of food, dietary supplements and unapproved drugs that contain ...

Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...

The U.S. Food and Drug Administration raised concerns over ink printing potentially running when exposed to high temperatures.